
Elisa Scarselli
scientistFemale0.0Global Dominance: 0.00%
Elisa Scarselli is the Chief Scientific Officer of Nouscom, a biopharmaceutical company focused on developing innovative cancer immunotherapies. She has played a key role in advancing the NOUS-209 vaccine, which has shown promising results in preventing cancer for individuals at high risk due to Lynch syndrome.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Elisa Scarselli is the scientific director of Nouscom who highlighted the potential of NOUS-209.
Vacuna para prevenir el cáncer demuestra eficacia en un ensayo clínicoListín Diario – oldest Dominican newspaper, est. 1889·
Dominican Republic· 2026-01-17

